HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Noa ancillaries

This article was originally published in The Rose Sheet

Executive Summary

Galactics series under Cacharel fragrance family comprises Foaming Bath Powder, Pressed Body Powder and Perfumed Body Gel scented with blossoming peonies and fresh greens of Noa women's fragrance, L'Oreal says. Bath and body powders retail for $25 and body gel is priced at $27.50 in department stores. Noa, targeted to teens 15-20 and women 25-30, was launched in 1,800 doors in 1999 (1"The Rose Sheet" Dec. 6, 1999, p. 3)

You may also be interested in...



Cosmair Takes Dual-Marketing Tactic With Noa, $50 Mil. In Sales Predicted

Cosmair's European Designer Fragrances will use a dual-marketing approach to sell Noa, its newest women's fragrance, which is slated to hit counters March 19. The scent's "strong, broad-based appeal" inspired Cosmair to target the scent to two groups of women, Senior VP/General Manager Jack Wiswall noted.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009226

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel